J-A. Vergilio | Researchain

Archive Network Publication Hotspot Collaboration

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where J-A. Vergilio is active.

Explore More

Publication

Featured researches published by J-A. Vergilio.

Annals of Oncology | 2017

88PPALB2 reversion mutations in breast, prostate, and ovarian carcinomas

S. Daniel; James Suh; Shakti Ramkissoon; J-A. Vergilio; E Severson; P.J. Stephens; J.S. Ross; Julia A. Elvin

Annals of Oncology | 2016

Comprehensive genomic profiling of 8,654 breast carcinoma reveals therapeutically targetable molecular subtypes beyond those defined by hormone-receptor expression

J.S. Ross; Julia A. Elvin; James Suh; J-A. Vergilio; Shakti Ramkissoon; Siraj M. Ali; V.A. Miller; P.J. Stephens

Annals of Oncology | 2018

867PDComprehensive genomic profiling (CGP) of chemotherapy-resistant, primary mediastinal nonseminomatous germ cell tumors (PMNSGCT)

A Necchi; G Bratslavsky; R J Corona; Jon Chung; S Z Millis; J-A Elvin; J-A. Vergilio; Shakti Ramkissoon; E Severson; S. Daniel; J K Killian; Siraj M. Ali; Alexa B. Schrock; V.A. Miller; Jeffrey S. Ross

Annals of Oncology | 2018

58PDPan-cancer analysis of ret fusions (FN) and rearrangements (RE) by genomic profiling of 158,360 tumors

Dean Pavlick; Shakti Ramkissoon; S. Daniel; Jonathan Keith Killian; J-A. Vergilio; E Severson; Garrett Michael Frampton; Julia A. Elvin; Jeffrey S. Ross

Annals of Oncology | 2018

151PRecurrent and metastatic carcinomas of the lacrimal gland: High frequency of ERBB2 driven disease

Nicolas Girard; R J Corona; Jon Chung; Sherri Z. Millis; Julia A. Elvin; J-A. Vergilio; Shakti Ramkissoon; E Severson; S. Daniel; Jonathan Keith Killian; Siraj M. Ali; Alexa B. Schrock; V.A. Miller; Jeffrey S. Ross

Annals of Oncology | 2017

1138PDImmune checkpoint inhibitor (ICPI) efficacy and resistance detected by comprehensive genomic profiling (CGP) in non-small cell lung cancer (NSCLC)

J.S. Ross; M.E. Goldberg; La Albacker; V. Agarwala; Julia A. Elvin; J-A. Vergilio; James Suh; Shakti Ramkissoon; E Severson; S. Daniel; Siraj M. Ali; Alexa B. Schrock; Garrett Michael Frampton; David Fabrizio; V.A. Miller; G. Singal; A. Abernethy; P.J. Stephens

Annals of Oncology | 2017

1217PDComprehensive genomic profiling (CGP) and tumor mutational burden (TMB) assessment in subtypes of metastatic melanoma

J.S. Ross; J.A. Carlson; Julia A. Elvin; J-A. Vergilio; James Suh; Shakti Ramkissoon; E Severson; S. Daniel; Siraj M. Ali; Alexa B. Schrock; David Fabrizio; Garrett Michael Frampton; V.A. Miller; P.J. Stephens; Douglas B. Johnson

Annals of Oncology | 2017

1701OComprehensive Genomic Profiling (CGP) of Thymic Gland Carcinomas

J.S. Ross; P. Vanden Borre; N. Almog; Alexa B. Schrock; Jon Chung; J-A. Vergilio; James Suh; Shakti Ramkissoon; E Severson; S. Daniel; Siraj M. Ali; V.A. Miller; P.J. Stephens; Julia A. Elvin

Annals of Oncology | 2017

240PDComprehensive genomic profiling of primary and metastatic CDH1 mutated classic and pleomorphic invasive lobular breast carcinomas reveals markers of hormonal therapy resistance and opportunities for targeted therapies

J.S. Ross; Julia A. Elvin; James Suh; J-A. Vergilio; Shakti Ramkissoon; E Severson; S. Daniel; Garrett Michael Frampton; David Fabrizio; Alexa B. Schrock; Siraj M. Ali; V.A. Miller; P.J. Stephens; Jon Chung

Annals of Oncology | 2017

433PDComprehensive genomic profiling of metastatic and relapsed thyroid gland carcinomas is associated with tumor type and reveals new routes to targeted therapies

J.S. Ross; P. Vanden Borre; N. Almog; Alexa B. Schrock; J-A. Vergilio; James Suh; Shakti Ramkissoon; E Severson; S. Daniel; Siraj M. Ali; V.A. Miller; P.J. Stephens; Julia A. Elvin; Daniel W. Bowles

Explore More